Skip to main content

Table 1 In-patient and ED asthma visits by self-reported race including demographic, clinical history of comorbidities, temporal and place-based risk factors

From: Racial differences in length of stay and readmission for asthma in the all of us research program

Characteristics

Overall

Asian

Black

HL

MENA

White

P-Value

Patients (%)

17,233

216 (1.3)

5293 (30.7)

3394 (19.7)

56 (0.3)

8274 (48.0)

 

Visits (%)

82,188

535 (0.7)

33,620 (40.9)

17,034 (20.7)

242 (0.3)

30,757 (37.4)

 

LOS per admission (mean (SD))

2.0 (4.09)

2.5 (4.8)

1.8 (4.0)

1.8 (3.8)

2.1 (3.4)

2.2 (4.3)

 < 0.001

Readmission within 30 days (%)

 No

64,326 (78.3)

455 (85.0)

25,694 (76.4)

13,483 (79.2)

202 (83.5)

24,492 (79.6)

 < 0.001

 Yes

17,862 (21.7)

80 (15.0)

7926 (23.6)

3551 (20.8)

40 (16.5)

6265 (20.4)

 

 Age at visit (mean (SD))

47.8 (15.1)

47.6 (17.1)

46.6 (13.4)

45.7 (15.5)

48.9 (17.2)

50.2 (16.2)

 < 0.001

Sex at birth (%)

 Female

63,419 (77.2)

422 (78.9)

25,292 (75.2)

14,010 (82.2)

122 (50.4)

23,573 (76.6)

 < 0.001

 Male

18,769 (22.8)

113 (21.1)

8328 (24.8)

3024 (17.8)

120 (49.6)

7184 (23.4)

 

Health insurance

 Private

17,319 (21.1)

204 (38.1)

5161 (15.4)

3065 (18.0)

38 (15.7)

8851 (28.8)

 < 0.001

 Public

64,869 (78.9)

331 (61.9)

28,459 (84.6)

13,969 (82.0)

204 (84.3)

21,906 (71.2)

 

Temporal and place-based

Season (%)

 Summer

20,276 (24.7)

125 (23.4)

8376 (24.9)

4145 (24.3)

45 (18.6)

7585 (24.7)

0.16

 Fall

20,336 (24.7)

134 (25.0)

8230 (24.5)

4201 (24.7)

68 (28.1)

7703 (25.0)

 

 Winter

20,410 (24.8)

123 (23.0)

8401 (25.0)

4280 (25.1)

72 (29.8)

7534 (24.5)

 

 Spring

21,166 (25.8)

153 (28.6)

8613 (25.6)

4408 (25.9)

57 (23.6)

7935 (25.8)

 

Day of admission (%)

 Weekday

63,661 (77.5)

427 (79.8)

25,659 (76.3)

13,430 (78.8)

181 (74.8)

23,964 (77.9)

 < 0.001

 Weekend

18,527 (22.5)

108 (20.2)

7961 (23.7)

3604 (21.2)

61 (25.2)

6793 (22.1)

 

 Deprivation (mean (SD))

0.33 (0.07)

0.31 (0.06)

0.35 (0.07)

0.36 (0.07)

0.35 (0.06)

0.30 (0.05)

 < 0.001

Comorbidities

AD (%)

 No

78,068 (95.0)

507 (94.8)

32,004 (95.2)

16,095 (94.5)

214 (88.4)

29,248 (95.1)

 < 0.001

 Yes

4120 (5.0)

28 (5.2)

1616 (4.8)

939 (5.5)

28 (11.6)

1509 (4.9)

 

AR (%)

 No

57,085 (69.5)

435 (81.3)

25,234 (75.1)

11,655 (68.4)

178 (73.6)

19,583 (63.7)

 < 0.001

 Yes

25,103 (30.5)

100 (18.7)

8386 (24.9)

5379 (31.6)

64 (26.4)

11,174 (36.3)

 

Cancer (%)

 No

44,989 (54.7)

311 (58.1)

20,662 (61.5)

9556 (56.1)

143 (59.1)

14,317 (46.5)

 < 0.001

 Yes

37,199 (45.3)

224 (41.9)

12,958 (38.5)

7478 (43.9)

99 (40.9)

16,440 (53.5)

 

CHD (%)

 No

59,527 (72.4)

435 (81.3)

24,089 (71.7)

12,797 (75.1)

155 (64.0)

22,051 (71.7)

 < 0.001

 Yes

22,661 (27.6)

100 (18.7)

9531 (28.3)

4237 (24.9)

87 (36.0)

8706 (28.3)

 

CKD (%)

 No

71,684 (87.2)

451 (84.3)

28,729 (85.5)

14,973 (87.9)

223 (92.1)

27,308 (88.8)

 < 0.001

 Yes

10,504 (12.8)

84 (15.7)

4891 (14.5)

2061 (12.1)

19 (7.9)

3449 (11.2)

 

COPD (%)

 No

56,674 (69.0)

441 (82.4)

22,022 (65.5)

11,973 (70.3)

183 (75.6)

22,055 (71.7)

 < 0.001

 Yes

25,514 (31.0)

94 (17.6)

11,598 (34.5)

5061 (29.7)

59 (24.4)

8702 (28.3)

 

Depression (%)

 No

35,495 (43.2)

391 (73.1)

16,410 (48.8)

7886 (46.3)

143 (59.1)

10,665 (34.7)

 < 0.001

 Yes

46,693 (56.8)

144 (26.9)

17,210 (51.2)

9148 (53.7)

99 (40.9)

20,092 (65.3)

 

Diabetes (%)

 No

52,065 (63.3)

400 (74.8)

20,080 (59.7)

10,747 (63.1)

166 (68.6)

20,672 (67.2)

 < 0.001

 Yes

30,123 (36.7)

135 (25.2)

13,540 (40.3)

6287 (36.9)

76 (31.4)

10,085 (32.8)

 

EoE (%)

 No

81,782 (99.5)

535 (100.0)

33,495 (99.6)

16,989 (99.7)

242 (100.0)

30,521 (99.2)

 < 0.001

 Yes

406 (0.5)

0 (0.0)

125 (0.4)

45 (0.3)

0 (0.0)

236 (0.8)

 

FA (%)

 No

79,717 (97.0)

524 (97.9)

32,866 (97.8)

16,521 (97.0)

239 (98.8)

29,567 (96.1)

 < 0.001

 Yes

2471 (3.0)

11 (2.1)

754 (2.2)

513 (3.0)

3 (1.2)

1190 (3.9)

 

GERD (%)

 No

37,165 (45.2)

343 (64.1)

16,157 (48.1)

9119 (53.5)

125 (51.7)

11,421 (37.1)

 < 0.001

 Yes

45,023 (54.8)

192 (35.9)

17,463 (51.9)

7915 (46.5)

117 (48.3)

19,336 (62.9)

 

HTA (%)

 No

31,021 (37.7)

262 (49.0)

11,022 (32.8)

7557 (44.4)

121 (50.0)

12,059 (39.2)

 < 0.001

 Yes

51,167 (62.3)

273 (51.0)

22,598 (67.2)

9477 (55.6)

121 (50.0)

18,698 (60.8)

 

Obesity (%)

 No

45,006 (54.8)

478 (89.3)

17,686 (52.6)

9931 (58.3)

180 (74.4)

16,731 (54.4)

 < 0.001

 Yes

37,182 (45.2)

57 (10.7)

15,934 (47.4)

7103 (41.7)

62 (25.6)

14,026 (45.6)

 

Psoriasis (%)

 No

79,314 (96.5)

523 (97.8)

33,207 (98.8)

16,488 (96.8)

231 (95.5)

28,865 (93.8)

 < 0.001

 Yes

2874 (3.5)

12 (2.2)

413 (1.2)

546 (3.2)

11 (4.5)

1892 (6.2)

 

Sleep apnea (%)

 No

59,240 (72.1)

444 (83.0)

24,583 (73.1)

13,527 (79.4)

191 (78.9)

20,495 (66.6)

 < 0.001

 Yes

22,948 (27.9)

91 (17.0)

9037 (26.9)

3507 (20.6)

51 (21.1)

10,262 (33.4)

 
  1. LOS Length of stay, SD Standard deviation, AD Atopic dermatitis, AR Allergic rhinitis, CHD Coronary heart disease, CKD Chronic kidney disease, COPD Chronic obstructive pulmonary disease, EoE Eosinophilic esophagitis, FA Food allergy, GERD Gastro-esophageal reflux disease, HL Hispanic/Latino, HTA Hypertension, MENA Middle Eastern and North Africa